Welcome
|
Vitala Therapeutics is a privately-held biopharmaceutical company that specializes in early disease intervention and chronic disease management. This constitutes a large, growing and underserved market due to an aging population as well as a lack of therapeutic innovation over the last decade. With a mandate of “strong health for life”, we believe that stopping disease development and progression is a more effective therapeutic approach than treating it at a late stage.
Vitala Therapeutics challenges conventional thinking around drug design and application but also leverages the best practices of pharmaceutical drug development, manufacturing and commercialization. As an affiliate company of Genyous Biomed International, Vitala Therapeutics leads the development, licensing and commercialization of Multifunctional Multitargeted™ (MFMT™) biopharmaceuticals for early disease intervention and chronic disease management. The first products being developed by Vitala Therapeutics are naturally-derived and patented MFMT therapies for men’s health and urology.
Vitala is also pioneering the development of MFMT™ biopharmaceutical global supply chains, from raw material sourcing to manufacturing, from small-scale clinical batches to large-scale commercial supply. Vitala has established relationships with world-class research facilities, best-of-breed pharmaceutical vendors and market-leading business partners, all of whom will support the supply of Vitala and Genyous MFMT™ therapies. Vitala is also building strong intellectual property around this capability and will control all aspects of the supply chain in order to ensure the highest product quality and safety for patients and health professionals. |